Companies: 10,795·Total market cap: $144.5T
NexgenRx Inc.

NexgenRx Inc.

NEGXFOTCHealthcare● Active
$0.20
$-0.07(-25.93%)
Market Cap$14223426
P/E Ratio
52W High$0.28
52W Low$0.19

NexgenRx Inc.(NEGXF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NEGXF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$17.46M$16.48M$13.85M$12.46M$11.88M
Cost of Revenue$4.22M$3.35M$3.03M$3.97M$3.39M
Gross Profit$13.25M$13.12M$10.82M$8.49M$8.49M
Gross Margin %(computed)75.85%79.65%78.14%68.16%71.47%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
G&A Expenses$0.00M$0.73M$0.74M$0.88M$0.75M
Total Operating Expenses$11.47M$11.92M$10.96M$8.42M$6.33M
Operating Income$1.78M$1.20M($0.14M)$0.08M$2.16M
Operating Margin %(computed)10.17%7.27%-1.04%0.64%18.20%
Interest Income$0.46M($0.14M)($0.12M)$0.21M$0.05M
Interest Expense$0.17M$0.03M$0.04M$0.15M$0.19M
Income Before Tax$1.93M$1.03M($0.31M)$0.13M$2.03M
Income Tax Expense$0.65M$0.41M$0.03M$0.16M($2.02M)
Net Income$1.29M$0.61M($0.33M)($0.02M)$4.05M
Net Margin %(computed)7.38%3.73%-2.40%-0.18%34.09%
Per Share & EBITDA
EPS (Basic)$0.01$0.01$-0.00$-0.00$0.06
Wtd Avg Shares71.12M70.93M70.53M70.34M70.34M
EBITDA$3.00M$2.32M$1.03M$1.68M$4.33M
EBITDA Margin %(computed)17.16%14.11%7.45%13.47%36.49%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · M

深入了解NexgenRx Inc.

关于NexgenRx Inc.(NEGXF)损益表

NexgenRx Inc.(NEGXF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NEGXF实现营收$0.02B,毛利润$0.01B(毛利率75.85%),净利润$0.00B(净利率7.38%)。

常见问题

NEGXF · 4 问

NexgenRx Inc.(NEGXF)2025财年营收为$0.02B,同比up6.0%。

NEGXF revenueNEGXF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09